Health Data Analytics Institute (HDAI), a US-based healthcare analytics company that uses artificial intelligence (AI) to support clinical decisions, has raised $31m in a Series C funding round.
HDAI will use the capital to install its HealthVision platform in additional health systems across the country.
HealthVision is currently being used by Houston Methodist Hospital in Houston, Texas, US.
The healthcare company is also working on several initiatives in collaboration with health systems including Cleveland Clinic, and Dana-Farber Cancer Institute in Massachusetts.
Incorporating explainable machine learning and generative AI, the HealthVision platform can quantify patient and population risks and identify actionable clinical improvement opportunities.
It can generate lists of patients who could benefit from specific interventions or general case management.
In addition to forecasting health risks at patient, practice, institution and/or regional levels, the platform assists in enhancing performance for clinicians and organisations.
HDAI board member and longtime healthcare investor Ed Kania said: "While the swirling hype about AI in healthcare continues to generate exciting claims but little of genuine impact, the HDAI team is actively working with leading healthcare organisations and clinicians to improve care in ways that deliver better outcomes.
"I am increasingly convinced that the Company's broad-based enterprise platform and remarkably cost-efficient business model can transform healthcare in the US."
HDAI lead investor Philippe Amouyal said: ''HDAI has firmly established itself through key partnerships with some of the top health systems in the country. We are confident that the company has the technology, resources, and team to deliver on the promise of AI in healthcare.
"We look forward to HDAI advancing its mission to enable system-wide efficiencies and improved patient care."
